Mr. Medardo Tomaquin Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy, Napa, CA 94558 Phone: 707-253-1009 Fax: 707-253-7269 |
Rosa Elena Olmos Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1141 Pear Tree Ln Ste 100, Napa, CA 94558 Phone: 707-254-1770 Fax: 707-254-1779 |
Mr. Jeremy David Ostrander Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2751 Napa Valley Corporate Dr, Napa, CA 94558 Phone: 707-259-8769 |
Marisa Mendieta Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy # 253m-1, Napa, CA 94558 Phone: 707-257-7395 |
Maya Simone Frazier Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 709 Franklin St, Napa, CA 94559 Phone: 707-255-0966 |
James Nicolis Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2310 1st St, Napa, CA 94559 Phone: 707-255-1855 Fax: 707-255-5621 |
Madelyn Parker Counselor Medicare: Not Enrolled in Medicare Practice Location: 3285 Claremont Way, Napa, CA 94558 Phone: 707-258-4490 |
Tracey Crow Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2100 Napa Vallejo Hwy Bldg 253, Napa, CA 94558 Phone: 707-255-8001 |
Miss Angela Marie Sanchez Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2310 1st St, Napa, CA 94559 Phone: 707-255-1855 Fax: 707-255-5621 |
Michael Joseph Hamilton, CADC II Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2261 Elm St, Napa, CA 94559 Phone: 707-253-4768 |
Ernest Henry Nunes Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2261 Elm St, Napa, CA 94559 Phone: 707-253-6046 |
Brooke Lyman Casey, LMFT Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 709 Franklin St, Napa, CA 94559 Phone: 707-326-9934 |
Mr. Joseph Kwok Chow Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2261 Elm St, Napa, CA 94559 Phone: 707-253-4785 |
Ms. Jennifer Merrell, CADACLL Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 701 School St, Napa, CA 94559 Phone: 707-226-1248 |
Calai Brown Counselor Medicare: Not Enrolled in Medicare Practice Location: 2751 Napa Valley Corporate Dr, Napa, CA 94558 Phone: 916-730-4734 |
Ms. Gretchen Oertel Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1546 1st St, Napa, CA 94559 Phone: 707-224-8266 |
Megan Marie Tarantino Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 829 Jefferson St, Napa, CA 94559 Phone: 707-515-0921 |
Josefina Nicolas, CADC-CAS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 2751 Napa Valley Corporate Dr Bldg A, Napa, CA 94558 Phone: 707-253-4692 Fax: 707-259-8690 |
Mrs. Lorraine V. Weeks Counselor Medicare: Not Enrolled in Medicare Practice Location: 3133 Laurel St, Napa, CA 94558 Phone: 707-255-3711 Fax: 707-255-8571 |
Mrs. Cheree Michelle Truso Counselor Medicare: Not Enrolled in Medicare Practice Location: 1046 Bella Dr, Napa, CA 94558 Phone: 707-257-7755 |
News Archive
Perrigo Company today announced that it has acquired rights to Novel Laboratories' pending ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep Kit (PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride for oral solution and bisacodyl delayed-release tablets), indicated for the cleansing of the colon as a preparation for colonoscopy in adults.
The National Institute for Clinical Excellence (NICE) has published on its website the preliminary recommendations of its Appraisal Committee on the use of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for the treatment of pulmonary hypertension in adults.
DiagnoCure, Inc., a life sciences company that develops and commercializes highâvalue cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.
A blood test for patients with coronary heart disease could help predict their risk for subsequent cardiovascular events or death, according to a study in the January 10 issue of JAMA: The Journal of the American Medical Association.
Patients who receive care in a for-profit hospital are more likely to be readmitted than those who receive care in nonprofit or public hospitals, according to a new study published by University of Illinois at Chicago researchers.
› Verified 6 days ago